Hershey (HSY)
(Delayed Data from NYSE)
$183.05 USD
-2.87 (-1.54%)
Updated Jun 26, 2024 04:00 PM ET
After-Market: $184.00 +0.95 (0.52%) 4:52 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$183.05 USD
-2.87 (-1.54%)
Updated Jun 26, 2024 04:00 PM ET
After-Market: $184.00 +0.95 (0.52%) 4:52 PM ET
3-Hold of 5 3
C Value A Growth F Momentum C VGM
Zacks News
Is Coca-Cola (KO) a Good Buy Option Just Before Q1 Earnings?
by Zacks Equity Research
Coca-Cola's (KO) market position, innovation and digital growth initiatives, along with solid business momentum, supported by robust consumer demand, place it well ahead of Q1 earnings.
Here's How Clorox (CLX) is Placed Ahead of Q3 Earnings Release
by Zacks Equity Research
Clorox (CLX) third-quarter results are likely to reflect challenges related to continued impacts of the recent cyberattack incident, inflationary costs and elevated SG&A expense.
Pilgrim's Pride (PPC) Queues for Q1 Earnings: What's in Store?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q1 performance will likely reflect gains from strategic business integrations and customer relationships. A focus on key customers and supply-chain improvements bodes well.
What Awaits The Estee Lauder Companies (EL) in Q3 Earnings?
by Zacks Equity Research
The Estee Lauder Companies' (EL) third-quarter performance will likely reflect strong growth across various emerging markets. However, unfavorable currency headwinds are a threat.
Mondelez (MDLZ) Gears Up for Q1 Earnings: What to Expect?
by Zacks Equity Research
Mondelez's (MDLZ) first-quarter results are likely to reflect strength in core categories like chocolates and biscuits, while cost inflation and volatile consumer behavior are a concern.
Investing in Sysco (SYY) Ahead of Q3 Earnings: Risks & Rewards
by Zacks Equity Research
Sysco's (SYY) extensive product range, proficiency of the sales team and strength of the supply chain position it well for Q3 earnings, though product cost inflation is a concern.
This is Why Hershey (HSY) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Hershey (HSY) have what it takes? Let's find out.
Hershey (HSY) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Hershey (HSY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hershey (HSY) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
Hershey (HSY) closed the most recent trading day at $187.08, moving +0.4% from the previous trading session.
Colgate (CL) to Retain Earnings Momentum in Q1: Wise to Buy?
by Zacks Equity Research
Colgate's (CL) aggressive pricing actions, along with solid business momentum, supported by robust consumer demand and innovation, should craft its successful earnings story.
Should You Buy Altria (MO) Ahead of Q1 Earnings Release?
by Zacks Equity Research
Despite facing several challenges, we maintain our belief in Altria's (MO) strong fundamentals and its potential for growth.
Helen of Troy (HELE) Q4 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Helen of Troy's (HELE) fourth-quarter performance is likely to reflect the adverse impact of pressured consumer spending. Persistent inflationary headwinds are a concern.
Hershey (HSY) Ascends While Market Falls: Some Facts to Note
by Zacks Equity Research
In the closing of the recent trading day, Hershey (HSY) stood at $184.86, denoting a +1.32% change from the preceding trading day.
Kimberly-Clark (KMB) Q1 Earnings Coming Up: Is a Beat Likely?
by Zacks Equity Research
Kimberly-Clark's (KMB) first-quarter results are likely to reflect manufacturing cost inflation and volume concerns in some markets, while brand strength and the FORCE program are likely to have aided.
Is Trending Stock Hershey Company (The) (HSY) a Buy Now?
by Zacks Equity Research
Zacks.com users have recently been watching Hershey (HSY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Hershey (HSY) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Hershey (HSY) closed the most recent trading day at $185.80, moving -1.95% from the previous trading session.
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Hershey (HSY) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
In the latest trading session, Hershey (HSY) closed at $189.50, marking a -1.32% move from the previous day.
TreeHouse Foods' (THS) Prudent Buyouts Help Navigate Challenges
by Zacks Equity Research
TreeHouse Foods (THS) battles supply-chain headwinds and macroeconomic challenges. However, the company's TMOS initiatives and focus on refining its portfolio offer respite.
The Zacks Analyst Blog Highlights UnitedHealth, Pfizer, BlackRock, The Hershey and Edison International
by Zacks Equity Research
UnitedHealth, Pfizer, BlackRock, The Hershey and Edison International are part of the Zacks top Analyst Blog.
Top Analyst Reports for UnitedHealth, Pfizer & BlackRock
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including UnitedHealth Group Incorporated (UNH), Pfizer Inc. (PFE) and BlackRock, Inc. (BLK).
Hershey (HSY) Benefits From Effective Pricing & Buyouts
by Zacks Equity Research
Hershey (HSY) undertakes buyouts to augment portfolio strength and boost revenues. The company's strategic pricing initiatives are yielding.
Beer Business to Aid Constellation Brands (STZ) in Q4 Earnings
by Zacks Equity Research
Constellation Brands' (STZ) Q4 results are expected to reflect gains from strong beer business trends as well as growth of Power Brands.
Hershey (HSY) Stock Falls Amid Market Uptick: What Investors Need to Know
by Zacks Equity Research
Hershey (HSY) closed the most recent trading day at $193.74, moving -1.13% from the previous trading session.
Will Hershey (HSY) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Hershey (HSY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.